4//SEC Filing
Sallin Aymeric 4
Accession 0001453687-23-000084
CIK 0001453687other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:17 PM ET
Size
18.4 KB
Accession
0001453687-23-000084
Insider Transaction Report
Form 4
Sallin Aymeric
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−6,410→ 0 totalExercise: $17.47Exp: 2027-06-15→ Common Stock (6,410 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−10,000→ 0 totalExercise: $12.75Exp: 2028-06-14→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−10,000→ 0 totalExercise: $2.10Exp: 2029-06-13→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−20,000→ 0 totalExercise: $3.00Exp: 2030-06-18→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−40,000→ 0 totalExercise: $4.01Exp: 2031-03-29→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−40,000→ 0 totalExercise: $3.31Exp: 2032-01-02→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13$0.93/sh−75,000$69,750→ 0 totalExercise: $1.13Exp: 2033-01-01→ Common Stock (75,000 underlying)
Footnotes (7)
- [F1]This option, which provided for vesting in full on June 14, 2018, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc.
- [F2]This option, which provided for vesting in full on June 13, 2019, was canceled in the Merger.
- [F3]This option, which provided for vesting in full on June 14, 2020, was canceled in the Merger.
- [F4]This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger.
- [F5]This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger.
- [F6]This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger.
- [F7]This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $69,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
Documents
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
Related Parties
1- filerCIK 0001677660
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:17 PM ET
- Size
- 18.4 KB